Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This phase II trial studies the side effects and how well nivolumab with or with ipilimumab works in treating patients with liver cancer that can be removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body\'s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Epistemonikos ID: ab7765d1147e3d070a66b93f2bc75c002f6b7421
First added on: May 20, 2024